Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 146 entries
Sorted by: Best Match Show Resources per page
Cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) in symptomatic cervical degenerative disc diseases (CDDDs): an updated meta-analysis of prospective randomized controlled trials (RCTs).

SpringerPlus

Xie L, Liu M, Ding F, Li P, Ma D.
PMID: 27516926
Springerplus. 2016 Jul 27;5(1):1188. doi: 10.1186/s40064-016-2851-8. eCollection 2016.

PURPOSE: This meta-analysis of randomized controlled trials (RCTs) aims to evaluate the efficacy and safety in cervical disc arthroplasty (CDA) and anterior cervical discectomy and fusion (ACDF) for treating cervical degenerative disc diseases (CDDDs).METHODS: The authors searched RCTs in...

Cite
Xie L, Liu M, Ding F, et al. Cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) in symptomatic cervical degenerative disc diseases (CDDDs): an updated meta-analysis of prospective randomized controlled trials (RCTs). Springerplus. 2016;5(1):1188doi: 10.1186/s40064-016-2851-8.
Xie, L., Liu, M., Ding, F., Li, P., & Ma, D. (2016). Cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) in symptomatic cervical degenerative disc diseases (CDDDs): an updated meta-analysis of prospective randomized controlled trials (RCTs). SpringerPlus, 5(1), 1188. https://doi.org/10.1186/s40064-016-2851-8
Xie, Lin, et al. "Cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) in symptomatic cervical degenerative disc diseases (CDDDs): an updated meta-analysis of prospective randomized controlled trials (RCTs)." SpringerPlus vol. 5,1 (2016): 1188. doi: https://doi.org/10.1186/s40064-016-2851-8
Xie L, Liu M, Ding F, Li P, Ma D. Cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) in symptomatic cervical degenerative disc diseases (CDDDs): an updated meta-analysis of prospective randomized controlled trials (RCTs). Springerplus. 2016 Jul 27;5(1):1188. doi: 10.1186/s40064-016-2851-8. eCollection 2016. PMID: 27516926; PMCID: PMC4963351.
Copy Download .nbib Format: NLM
Lower Back Symptoms in Adolescent Soccer Players: Predictors of Functional Recovery.

Orthopaedic journal of sports medicine

Shah T, Cloke DJ, Rushton S, Shirley MD, Deehan DJ.
PMID: 26535318
Orthop J Sports Med. 2014 Apr 17;2(4):2325967114529703. doi: 10.1177/2325967114529703. eCollection 2014 Apr.

BACKGROUND: There are little published data on factors relating to low back pain in the younger athletic population.HYPOTHESIS: Independent predictors of recovery and return to participation in sports could be determined by event analysis, which investigates the impacts of...

Cite
Shah T, Cloke DJ, Rushton S, et al. Lower Back Symptoms in Adolescent Soccer Players: Predictors of Functional Recovery. Orthop J Sports Med. 2014;2(4):2325967114529703doi: 10.1177/2325967114529703.
Shah, T., Cloke, D. J., Rushton, S., Shirley, M. D., & Deehan, D. J. (2014). Lower Back Symptoms in Adolescent Soccer Players: Predictors of Functional Recovery. Orthopaedic journal of sports medicine, 2(4), 2325967114529703. https://doi.org/10.1177/2325967114529703
Shah, Talib, et al. "Lower Back Symptoms in Adolescent Soccer Players: Predictors of Functional Recovery." Orthopaedic journal of sports medicine vol. 2,4 (2014): 2325967114529703. doi: https://doi.org/10.1177/2325967114529703
Shah T, Cloke DJ, Rushton S, Shirley MD, Deehan DJ. Lower Back Symptoms in Adolescent Soccer Players: Predictors of Functional Recovery. Orthop J Sports Med. 2014 Apr 17;2(4):2325967114529703. doi: 10.1177/2325967114529703. eCollection 2014 Apr. PMID: 26535318; PMCID: PMC4555597.
Copy Download .nbib Format: NLM
The structure of tri(cyclohexyl)tin chloride between 108 and 298 K: a compound in which molecular dimensions vary with temperature.

Inorganic chemistry

Asadi A, Eaborn C, Hitchcock PB, Meehan MM, Smith JD.
PMID: 12817973
Inorg Chem. 2003 Jun 30;42(13):4141-6. doi: 10.1021/ic026272f.

Care is necessary when relating physical data obtained at one temperature on compounds showing significant intermolecular interactions to X-ray data obtained at other temperatures. This is revealed by the determination of the structure of tri(cyclohexyl)tin chloride at nine different...

Cite
Asadi A, Eaborn C, Hitchcock PB, et al. The structure of tri(cyclohexyl)tin chloride between 108 and 298 K: a compound in which molecular dimensions vary with temperature. Inorg Chem. 2003;42(13):4141-6doi: 10.1021/ic026272f.
Asadi, A., Eaborn, C., Hitchcock, P. B., Meehan, M. M., & Smith, J. D. (2003). The structure of tri(cyclohexyl)tin chloride between 108 and 298 K: a compound in which molecular dimensions vary with temperature. Inorganic chemistry, 42(13), 4141-6. https://doi.org/10.1021/ic026272f
Asadi, Ashrafomolouk, et al. "The structure of tri(cyclohexyl)tin chloride between 108 and 298 K: a compound in which molecular dimensions vary with temperature." Inorganic chemistry vol. 42,13 (2003): 4141-6. doi: https://doi.org/10.1021/ic026272f
Asadi A, Eaborn C, Hitchcock PB, Meehan MM, Smith JD. The structure of tri(cyclohexyl)tin chloride between 108 and 298 K: a compound in which molecular dimensions vary with temperature. Inorg Chem. 2003 Jun 30;42(13):4141-6. doi: 10.1021/ic026272f. PMID: 12817973.
Copy Download .nbib Format: NLM
How do general practitioners manage alcohol-misusing patients? Results from a national survey of GPs in England and Wales.

Drug and alcohol review

Deehan A, Templeton L, Taylor C, Drummond C, Strang J.
PMID: 16203492
Drug Alcohol Rev. 1998 Sep;17(3):259-66. doi: 10.1080/09595239800187091.

The appropriateness of the primary care setting to undertake health promotional activities has been emphasized, but little is known about the clinical work of GPs with patients misusing alcohol. This study examines how GPs managed alcohol-misusing patients. A 20%...

Cite
Deehan A, Templeton L, Taylor C, et al. How do general practitioners manage alcohol-misusing patients? Results from a national survey of GPs in England and Wales. Drug Alcohol Rev. 1998;17(3):259-66doi: 10.1080/09595239800187091.
Deehan, A., Templeton, L., Taylor, C., Drummond, C., & Strang, J. (1998). How do general practitioners manage alcohol-misusing patients? Results from a national survey of GPs in England and Wales. Drug and alcohol review, 17(3), 259-66. https://doi.org/10.1080/09595239800187091
Deehan, A, et al. "How do general practitioners manage alcohol-misusing patients? Results from a national survey of GPs in England and Wales." Drug and alcohol review vol. 17,3 (1998): 259-66. doi: https://doi.org/10.1080/09595239800187091
Deehan A, Templeton L, Taylor C, Drummond C, Strang J. How do general practitioners manage alcohol-misusing patients? Results from a national survey of GPs in England and Wales. Drug Alcohol Rev. 1998 Sep;17(3):259-66. doi: 10.1080/09595239800187091. PMID: 16203492.
Copy Download .nbib Format: NLM
55-year-old man with ulcers in inguinal fold and intergluteal cleft found to have systemic Langerhans cell histiocytosis.

JAAD case reports

Mu EW, Khurram NA, Pei Z, Feng H, Cassai N, Meehan SA, Latkowski JA.
PMID: 30238052
JAAD Case Rep. 2018 Sep 18;4(8):837-840. doi: 10.1016/j.jdcr.2018.05.016. eCollection 2018 Sep.

No abstract available.

Cite
Mu EW, Khurram NA, Pei Z, et al. 55-year-old man with ulcers in inguinal fold and intergluteal cleft found to have systemic Langerhans cell histiocytosis. JAAD Case Rep. 2018;4(8):837-840doi: 10.1016/j.jdcr.2018.05.016.
Mu, E. W., Khurram, N. A., Pei, Z., Feng, H., Cassai, N., Meehan, S. A., & Latkowski, J. A. (2018). 55-year-old man with ulcers in inguinal fold and intergluteal cleft found to have systemic Langerhans cell histiocytosis. JAAD case reports, 4(8), 837-840. https://doi.org/10.1016/j.jdcr.2018.05.016
Mu, Euphemia W, et al. "55-year-old man with ulcers in inguinal fold and intergluteal cleft found to have systemic Langerhans cell histiocytosis." JAAD case reports vol. 4,8 (2018): 837-840. doi: https://doi.org/10.1016/j.jdcr.2018.05.016
Mu EW, Khurram NA, Pei Z, Feng H, Cassai N, Meehan SA, Latkowski JA. 55-year-old man with ulcers in inguinal fold and intergluteal cleft found to have systemic Langerhans cell histiocytosis. JAAD Case Rep. 2018 Sep 18;4(8):837-840. doi: 10.1016/j.jdcr.2018.05.016. eCollection 2018 Sep. PMID: 30238052; PMCID: PMC6143693.
Copy Download .nbib Format: NLM
What drives 'first-time testers' to test for HIV at community-based HIV testing services?.

Public health action

Meehan SA, Draper HR, Burger R, Beyers N.
PMID: 29584797
Public Health Action. 2017 Dec 21;7(4):304-306. doi: 10.5588/pha.17.0064.

Drivers of and barriers to testing are not well understood for those who have never been tested previously and now self-initiate at a community-based human immuno-deficiency virus (HIV) testing service (CB-HTS). This descriptive study enrolled 229 first-time testers. Participants...

Cite
Meehan SA, Draper HR, Burger R, et al. What drives 'first-time testers' to test for HIV at community-based HIV testing services?. Public Health Action. 2017;7(4):304-306doi: 10.5588/pha.17.0064.
Meehan, S. A., Draper, H. R., Burger, R., & Beyers, N. (2017). What drives 'first-time testers' to test for HIV at community-based HIV testing services?. Public health action, 7(4), 304-306. https://doi.org/10.5588/pha.17.0064
Meehan, S-A, et al. "What drives 'first-time testers' to test for HIV at community-based HIV testing services?." Public health action vol. 7,4 (2017): 304-306. doi: https://doi.org/10.5588/pha.17.0064
Meehan SA, Draper HR, Burger R, Beyers N. What drives 'first-time testers' to test for HIV at community-based HIV testing services?. Public Health Action. 2017 Dec 21;7(4):304-306. doi: 10.5588/pha.17.0064. PMID: 29584797; PMCID: PMC5753785.
Copy Download .nbib Format: NLM
Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans.

Journal of caffeine research

He H, Ma D, Crone LB, Butawan M, Meibohm B, Bloomer RJ, Yates CR.
PMID: 28875060
J Caffeine Res. 2017 Sep 01;7(3):95-102. doi: 10.1089/jcr.2017.0006.

No abstract available.

Cite
He H, Ma D, Crone LB, et al. Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans. J Caffeine Res. 2017;7(3):95-102doi: 10.1089/jcr.2017.0006.
He, H., Ma, D., Crone, L. B., Butawan, M., Meibohm, B., Bloomer, R. J., & Yates, C. R. (2017). Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans. Journal of caffeine research, 7(3), 95-102. https://doi.org/10.1089/jcr.2017.0006
He, Hui, et al. "Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans." Journal of caffeine research vol. 7,3 (2017): 95-102. doi: https://doi.org/10.1089/jcr.2017.0006
He H, Ma D, Crone LB, Butawan M, Meibohm B, Bloomer RJ, Yates CR. Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans. J Caffeine Res. 2017 Sep 01;7(3):95-102. doi: 10.1089/jcr.2017.0006. PMID: 28875060; PMCID: PMC5582588.
Copy Download .nbib Format: NLM
Considerations in the selection of healthcare providers for mothers and children in Bo, Sierra Leone: reputation, cost and location.

International health

Jacobsen KH, Ansumana R, Abdirahman HA, Bockarie AS, Bangura U, Meehan KA, Jimmy DH, Malanoski AP, Sundufu AJ, Stenger DA.
PMID: 24029678
Int Health. 2012 Dec;4(4):307-13. doi: 10.1016/j.inhe.2012.09.004.

The factors that influence the selection of a healthcare provider once the decision to seek care has been made can be summarized using a triad of cost, location and reputation. The goal of this study was to identify which...

Cite
Jacobsen KH, Ansumana R, Abdirahman HA, et al. Considerations in the selection of healthcare providers for mothers and children in Bo, Sierra Leone: reputation, cost and location. Int Health. 2012;4(4):307-13doi: 10.1016/j.inhe.2012.09.004.
Jacobsen, K. H., Ansumana, R., Abdirahman, H. A., Bockarie, A. S., Bangura, U., Meehan, K. A., Jimmy, D. H., Malanoski, A. P., Sundufu, A. J., & Stenger, D. A. (2012). Considerations in the selection of healthcare providers for mothers and children in Bo, Sierra Leone: reputation, cost and location. International health, 4(4), 307-13. https://doi.org/10.1016/j.inhe.2012.09.004
Jacobsen, Kathryn H, et al. "Considerations in the selection of healthcare providers for mothers and children in Bo, Sierra Leone: reputation, cost and location." International health vol. 4,4 (2012): 307-13. doi: https://doi.org/10.1016/j.inhe.2012.09.004
Jacobsen KH, Ansumana R, Abdirahman HA, Bockarie AS, Bangura U, Meehan KA, Jimmy DH, Malanoski AP, Sundufu AJ, Stenger DA. Considerations in the selection of healthcare providers for mothers and children in Bo, Sierra Leone: reputation, cost and location. Int Health. 2012 Dec;4(4):307-13. doi: 10.1016/j.inhe.2012.09.004. PMID: 24029678.
Copy Download .nbib Format: NLM
Mirtazapine-induced hyperpigmentation with type II histopathologic findings.

JAAD case reports

Sukhdeo K, Yoon GH, Rothman L, Meehan SA, Levin MK, Kim RH.
PMID: 30511003
JAAD Case Rep. 2018 Nov 14;4(10):1077-1079. doi: 10.1016/j.jdcr.2018.09.022. eCollection 2018 Nov.

No abstract available.

Cite
Sukhdeo K, Yoon GH, Rothman L, et al. Mirtazapine-induced hyperpigmentation with type II histopathologic findings. JAAD Case Rep. 2018;4(10):1077-1079doi: 10.1016/j.jdcr.2018.09.022.
Sukhdeo, K., Yoon, G. H., Rothman, L., Meehan, S. A., Levin, M. K., & Kim, R. H. (2018). Mirtazapine-induced hyperpigmentation with type II histopathologic findings. JAAD case reports, 4(10), 1077-1079. https://doi.org/10.1016/j.jdcr.2018.09.022
Sukhdeo, Kumar, et al. "Mirtazapine-induced hyperpigmentation with type II histopathologic findings." JAAD case reports vol. 4,10 (2018): 1077-1079. doi: https://doi.org/10.1016/j.jdcr.2018.09.022
Sukhdeo K, Yoon GH, Rothman L, Meehan SA, Levin MK, Kim RH. Mirtazapine-induced hyperpigmentation with type II histopathologic findings. JAAD Case Rep. 2018 Nov 14;4(10):1077-1079. doi: 10.1016/j.jdcr.2018.09.022. eCollection 2018 Nov. PMID: 30511003; PMCID: PMC6250903.
Copy Download .nbib Format: NLM
Two Unique Cases of X-linked SCID: A Diagnostic Challenge in the Era of Newborn Screening.

Frontiers in pediatrics

Purswani P, Meehan CA, Kuehn HS, Chang Y, Dasso JF, Meyer AK, Ujhazi B, Csomos K, Lindsay D, Alberdi T, Joychan S, Trotter J, Duff C, Ellison M, Bleesing J, Kumanovics A, Comeau AM, Hale JE, Notarangelo LD, Torgersen TR, Ochs HD, Sriaroon P, Oshrine B, Petrovic A, Rosenzweig SD, Leiding JW, Walter JE.
PMID: 31024866
Front Pediatr. 2019 Apr 05;7:55. doi: 10.3389/fped.2019.00055. eCollection 2019.

In the era of newborn screening (NBS) for severe combined immunodeficiency (SCID) and the possibility of gene therapy (GT), it is important to link SCID phenotype to the underlying genetic disease. In western countries, X-linked interleukin 2 receptor gamma...

Cite
Purswani P, Meehan CA, Kuehn HS, et al. Two Unique Cases of X-linked SCID: A Diagnostic Challenge in the Era of Newborn Screening. Front Pediatr. 2019;7:55doi: 10.3389/fped.2019.00055.
Purswani, P., Meehan, C. A., Kuehn, H. S., Chang, Y., Dasso, J. F., Meyer, A. K., Ujhazi, B., Csomos, K., Lindsay, D., Alberdi, T., Joychan, S., Trotter, J., Duff, C., Ellison, M., Bleesing, J., Kumanovics, A., Comeau, A. M., Hale, J. E., Notarangelo, L. D., Torgersen, T. R., Ochs, H. D., Sriaroon, P., Oshrine, B., Petrovic, A., Rosenzweig, S. D., Leiding, J. W., & Walter, J. E. (2019). Two Unique Cases of X-linked SCID: A Diagnostic Challenge in the Era of Newborn Screening. Frontiers in pediatrics, 755. https://doi.org/10.3389/fped.2019.00055
Purswani, Pooja, et al. "Two Unique Cases of X-linked SCID: A Diagnostic Challenge in the Era of Newborn Screening." Frontiers in pediatrics vol. 7 (2019): 55. doi: https://doi.org/10.3389/fped.2019.00055
Purswani P, Meehan CA, Kuehn HS, Chang Y, Dasso JF, Meyer AK, Ujhazi B, Csomos K, Lindsay D, Alberdi T, Joychan S, Trotter J, Duff C, Ellison M, Bleesing J, Kumanovics A, Comeau AM, Hale JE, Notarangelo LD, Torgersen TR, Ochs HD, Sriaroon P, Oshrine B, Petrovic A, Rosenzweig SD, Leiding JW, Walter JE. Two Unique Cases of X-linked SCID: A Diagnostic Challenge in the Era of Newborn Screening. Front Pediatr. 2019 Apr 05;7:55. doi: 10.3389/fped.2019.00055. eCollection 2019. PMID: 31024866; PMCID: PMC6460992.
Copy Download .nbib Format: NLM
COVID-19 Vaccine Acceptability Among Clients and Staff of Homeless Shelters in Detroit, Michigan, February 2021.

Health promotion practice

Meehan AA, Yeh M, Gardner A, DeFoe TL, Garcia A, Vander Kelen P, Montgomery MP, Tippins AE, Carmichael AE, Gibbs Chw R, Caidi H, Mosites E, Rehman N.
PMID: 34693782
Health Promot Pract. 2022 Jan;23(1):35-41. doi: 10.1177/15248399211049202. Epub 2021 Oct 23.

Understanding COVID-19 vaccine acceptability among clients and staff of homeless shelters can inform public health efforts focused on communicating with and educating this population about COVID-19 vaccines and thus improve vaccine uptake. The objective of this study was to...

Cite
Meehan AA, Yeh M, Gardner A, et al. COVID-19 Vaccine Acceptability Among Clients and Staff of Homeless Shelters in Detroit, Michigan, February 2021. Health Promot Pract. 2021;23(1):35-41doi: 10.1177/15248399211049202.
Meehan, A. A., Yeh, M., Gardner, A., DeFoe, T. L., Garcia, A., Vander Kelen, P., Montgomery, M. P., Tippins, A. E., Carmichael, A. E., Gibbs Chw, R., Caidi, H., Mosites, E., & Rehman, N. (2022). COVID-19 Vaccine Acceptability Among Clients and Staff of Homeless Shelters in Detroit, Michigan, February 2021. Health promotion practice, 23(1), 35-41. https://doi.org/10.1177/15248399211049202
Meehan, Ashley A, et al. "COVID-19 Vaccine Acceptability Among Clients and Staff of Homeless Shelters in Detroit, Michigan, February 2021." Health promotion practice vol. 23,1 (2022): 35-41. doi: https://doi.org/10.1177/15248399211049202
Meehan AA, Yeh M, Gardner A, DeFoe TL, Garcia A, Vander Kelen P, Montgomery MP, Tippins AE, Carmichael AE, Gibbs Chw R, Caidi H, Mosites E, Rehman N. COVID-19 Vaccine Acceptability Among Clients and Staff of Homeless Shelters in Detroit, Michigan, February 2021. Health Promot Pract. 2022 Jan;23(1):35-41. doi: 10.1177/15248399211049202. Epub 2021 Oct 23. PMID: 34693782.
Copy Download .nbib Format: NLM
Estimating the global burden of Epstein-Barr virus-related cancers.

Journal of cancer research and clinical oncology

Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ.
PMID: 34705104
J Cancer Res Clin Oncol. 2022 Jan;148(1):31-46. doi: 10.1007/s00432-021-03824-y. Epub 2021 Oct 27.

BACKGROUND: More than 90% of the adult population globally is chronically infected by the Epstein-Barr virus (EBV). It is well established that EBV is associated with a number of malignancies, and advances in knowledge of EBV-related malignancies are being...

Cite
Wong Y, Meehan MT, Burrows SR, et al. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol. 2021;148(1):31-46doi: 10.1007/s00432-021-03824-y.
Wong, Y., Meehan, M. T., Burrows, S. R., Doolan, D. L., & Miles, J. J. (2022). Estimating the global burden of Epstein-Barr virus-related cancers. Journal of cancer research and clinical oncology, 148(1), 31-46. https://doi.org/10.1007/s00432-021-03824-y
Wong, Yide, et al. "Estimating the global burden of Epstein-Barr virus-related cancers." Journal of cancer research and clinical oncology vol. 148,1 (2022): 31-46. doi: https://doi.org/10.1007/s00432-021-03824-y
Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol. 2022 Jan;148(1):31-46. doi: 10.1007/s00432-021-03824-y. Epub 2021 Oct 27. PMID: 34705104.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 146 entries